Innospec Inc

Basic Materials · Specialty Chemicals

93.20$ +0.0% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

Innospec Inc (IOSP) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 491 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement IOSP
Line item	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	LTM
Revenue	464	495	500	435	443	467	441	440	442	456	453	491	1,842
Cost of Revenue	327	339	345	308	319	331	316	317	325	328	330	353	1,336
Gross Profit	137	156	156	127	124	136	125	123	117	127	124	138	506
Research & Development	12	8.9	14	14	11	13	13	14	14	11	13	14	52
Selling, General & Administrative	82	102	89	72	65	228	69	75	72	69	79	84	304
Total Operating Expenses	95	111	105	86	79	95	83	89	86	80	92	99	356
Operating Income	42	45	51	41	46	41	43	34	31	47	32	40	150
Interest Expense	0.8	0.9	–	2.1	–	–	–	–	–	–	–	–	–
Pre-Tax Income	48	45	55	44	45	-103	44	32	12	50	40	42	143
Income Tax Expense	8.3	7.5	14	13	11	-32	12	8.4	-1.4	2.9	9.1	10	21
Net Income	39	38	41	31	33	-70	33	24	13	47	30	31	122
EBITDA	54	56	63	52	59	48	54	46	23	60	50	39	172

LTM = last twelve months (sum of the four most recent quarters).

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings